Stay updated on Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.

Latest updates to the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. The prior revision v3.4.2 was replaced.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedRevision tag updated to v3.4.2 and the prior funding-status notice (including the older revision v3.4.1) was removed. No study details, eligibility criteria, endpoints, or results information were modified.SummaryDifference0.4%

- Check40 days agoChange DetectedA site-wide government funding notice was added and a version update was applied (v3.4.1), replacing the previous v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check47 days agoChange DetectedShow glossary added to the page. The page metadata now includes 'Last Update Submitted that Met QC Criteria' and 'Revision: v3.4.0', while older QC labels and references to 'No FEAR Act data' were removed.SummaryDifference0.2%

- Check61 days agoChange DetectedThe page shows Revision: v3.3.4 (replacing v3.3.3) in the footer. The study details, eligibility criteria, locations, and contacts remain unchanged.SummaryDifference0.1%

- Check83 days agoChange DetectedAdded a dedicated Locations section with a Texas site and removed the separate Texas Locations listing; removed HHS Vulnerability Disclosure information and updated to Revision v3.3.3.SummaryDifference0.2%

Stay in the know with updates to Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab and HPV-16 Vaccine for Incurable Solid Tumors Clinical Trial page.